# Impact of dietary selenium and blood concentration on liver function: a population-based study

**Authors:** Qiaoli Liang, Ruihua Huang, Ziming Peng, Menglong Zou

PMC · DOI: 10.3389/fnut.2024.1415288 · 2024-07-17

## TL;DR

This study finds that selenium intake and blood levels are linked to changes in liver function markers, with effects varying by age, gender, and BMI.

## Contribution

The study provides new population-based evidence on the relationship between selenium and liver function parameters.

## Key findings

- Higher dietary selenium intake was positively associated with ALT and the ALT/AST ratio.
- Blood selenium levels were positively linked to ALT, AST, and the ALT/AST ratio, but negatively with ALP.
- The effects of selenium on liver function varied by age, gender, and BMI.

## Abstract

Evidence on the association between selenium and liver function parameters is limited and controversial.

Data on dietary selenium intake, blood selenium concentration, and liver function parameters were obtained from the National Health and Nutrition Examination Survey (NHANES) 2017–2020. Associations between selenium (dietary intake and blood concentration) and liver function parameters [alanine aminotransferase (ALT), aspartate aminotransferase (AST), the ALT/AST ratio, gamma-glutamyl transferase (GGT), and alkaline phosphatase (ALP)] were assessed using multivariate linear regression models. Subgroup analyses and interaction tests were conducted to examine differences in associations according to age, gender, body mass index (BMI), diabetes, and physical activity.

The study included 6,869 participants after screening. The multivariate linear regression model revealed that dietary selenium intake was positively associated with ALT (β = 0.112, 95% CI = 0.041, 0.183) and the ALT/AST ratio (β = 0.002, 95% CI = 0.001, 0.004) after adjustment for covariates. Results of blood selenium concentration also showed that higher blood selenium levels were positively associated with ALT (β = 0.436, 95% CI = 0.308, 0.564), AST (β = 0.112, 95% CI = 0.015, 0.208), and the ALT/AST ratio (β = 0.012, 95% CI = 0.009, 0.015). However, ALP decreased with increasing blood selenium concentration (β = −0.207, 95% CI = −0.414, −0.000). In addition, we found significant differences in the effect of selenium on liver function parameters according to age, gender, and BMI.

Dietary selenium intake and blood concentration affect liver function parameters. These findings suggest that further research is needed to explore these associations to promote liver health and disease prevention.

## Linked entities

- **Chemicals:** selenium (PubChem CID 6326970)

## Full-text entities

- **Genes:** GGT1 (gamma-glutamyltransferase 1) [NCBI Gene 2678] {aka CD224, D22S672, D22S732, GGT, GGT 1, GGTD}, SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, GGTLC5P (gamma-glutamyltransferase light chain 5 pseudogene) [NCBI Gene 653590] {aka GGT}, ALPP (alkaline phosphatase, placental) [NCBI Gene 250] {aka ALP, PALP, PLAP, PLAP-1}, GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}
- **Diseases:** diabetes (MESH:D003920)
- **Chemicals:** selenium (MESH:D012643)

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11288839/full.md

---
Source: https://tomesphere.com/paper/PMC11288839